Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.41M 2.09M 1.95M 1.79M 230M 3.42M 22.88M 8.97M 115M 9.07M 8.87M 381M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.12M 2.7M 2.52M 2.32M 296M 4.42M 29.55M 11.58M 149M 11.71M 11.45M 492M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2004-06-16 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2004-06-16 | |
J. Lievonen
CHM | Chairman | - | 2021-07-04 |
Jeffrey Shon
BRD | Director/Board Member | - | 2021-07-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.4M | |
| +0.90% | +0.21% | -0.74% | +13.87% | 48B | |
| +1.98% | +7.31% | +430.66% | +532.17% | 41.13B | |
| +3.44% | -2.84% | +29.17% | +8.81% | 37.56B | |
| +1.40% | -0.89% | +7.63% | +61.93% | 35.91B | |
| +2.42% | +7.27% | +14.90% | +44.79% | 29.86B | |
| -0.16% | -4.02% | - | - | 16.12B | |
| +2.20% | +2.94% | +35.92% | +127.15% | 16.05B | |
| +1.25% | +1.69% | +4.72% | +18.26% | 13.76B | |
| +4.25% | -9.28% | -0.78% | -35.46% | 12.1B | |
| Average | -1.69% | -2.15% | +65.18% | +96.44% | 27.83B | |
| Weighted average by Cap. | +1.91% | -1.29% | +85.86% | +120.78% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.28M -1.11M -1.04M -955K -122M -1.82M -12.18M -4.78M -61.28M -4.83M -4.72M -203M | 5M 3.56M 3.09M 2.88M 2.65M 339M 5.06M 33.81M 13.25M 170M 13.4M 13.1M 563M |
| Net Debt | 795K 567K 491K 458K 421K 53.95M 804K 5.38M 2.11M 27.05M 2.13M 2.08M 89.47M | 986K 703K 609K 568K 523K 66.89M 997K 6.67M 2.61M 33.54M 2.64M 2.58M 111M |
Employees
-
